Unicycive, which is seeking an FDA green light for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease who are on dialysis, Monday said the agency set a target ...
FDA sets PDUFA Action Date of June 28, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback